CASP3 and neoplasm: Since the extent of apoptosis was a strong predictor for in vivo tumor growth inhibition by zotatifin (Figure 2D), we further measured fold induction of apoptosis (by caspase 3/7 activation) relative to control DMSO for all combination treatments.